EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhanced HPV16 E6/E7+ tumor eradication via induction of tumor-specific T cells by therapeutic vaccination with virosomes presenting synthetic long peptides

Toon Stegmann, Anna-Sophia Wiekmeijer, Kitty Kwappenberg, Suzanne van Duikeren, Farien Bhoelan, Denzel Bemelman, Thomas J M Beenakker, Willem-Jan Krebber, Ramon Arens, Cornelis J M Melief

Cancer Immunology, Immunotherapy · 2023

DOI: 10.1007/s00262-023-03462-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2023. Verfasst von Toon Stegmann und 9 weiteren Autor:innen. Beteiligte Einrichtung: Mymetics BV, J.H, Oortweg 21, 2333 CH, Leiden, The Netherlands. toon.stegmann@mymetics.com. Hauptthemen laut MEDLINE: Neoplasms, Cancer Vaccines. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic cancer vaccines trigger CD4 + and CD8 + T cell responses capable of established tumor eradication. Current platforms include DNA, mRNA and synthetic long peptide (SLP) vaccines, all aiming at robust T cell responses. SLPs linked to the Amplivant® adjuvant (Amplivant-SLP) have shown effective delivery to dendritic cells, resulting in improved immunogenicity in mice. We have now tested virosomes as a delivery vehicle for SLPs. Virosomes are nanoparticles made from influenza virus membranes and have been used as vaccines for a variety of antigens. Amplivant-SLP virosomes induced the expansion of more antigen-specific CD8 + T memory cells in ex vivo experiments with human PBMCs than Amplivant-SLP conjugates alone. The immune response could be further improved by including the adjuvants QS-21 and 3D-PHAD in the virosomal membrane. In these experiments, the SLPs were anchored in the membrane through the hydrophobic Amplivant adjuvant. In a therapeutic mouse model of HPV16 E6/E7 + cancer, mice were vaccinated with virosomes loaded with either Amplivant-conjugated SLPs or lipid-coupled SLPs. Vaccination with both types of virosomes significantly improved the control of tumor outgrowth, leading to elimination of the tumors in about half the animals for the best combinations of adjuvants and to their survival beyond 100 days.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsCancer VaccinesHumansAnimalsMiceVirosomesHuman papillomavirus 16Papillomavirus E7 ProteinsVaccinationAdjuvants, ImmunologicCD8-Positive T-LymphocytesPeptidesVaccines, SyntheticMice, Inbred C57BL

Stichwörter der Autor:innen

Cancer immunotherapyCancer vaccinesCervical cancerHuman Papilloma virus

Substanzen

VirosomesPapillomavirus E7 ProteinsAdjuvants, ImmunologicCancer VaccinesPeptidesVaccines, Synthetic

Autor:innen und Institutionen

  • Mymetics BV, J.H, Oortweg 21, 2333 CH, Leiden, The Netherlands. toon.stegmann@mymetics.com.
  • ISA Pharmaceuticals BV, De Limes 7, 2342 DH, Oegstgeest, The Netherlands.
  • Immunology department, Leiden Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
  • Mymetics BV, J.H, Oortweg 21, 2333 CH, Leiden, The Netherlands.

Zitieren

APA

Stegmann, T., Wiekmeijer, A. S., Kwappenberg, K., van Duikeren, S., Bhoelan, F., Bemelman, D., Beenakker, T. J. M., Krebber, W. J., Arens, R., & Melief, C. J. M. (2023). Enhanced HPV16 E6/E7+ tumor eradication via induction of tumor-specific T cells by therapeutic vaccination with virosomes presenting synthetic long peptides. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-023-03462-y

Vancouver

Stegmann T, Wiekmeijer AS, Kwappenberg K, van Duikeren S, Bhoelan F, Bemelman D, et al. Enhanced HPV16 E6/E7+ tumor eradication via induction of tumor-specific T cells by therapeutic vaccination with virosomes presenting synthetic long peptides. Cancer Immunology, Immunotherapy. 2023. doi:10.1007/s00262-023-03462-y

BibTeX
@article{Stegmann2023,
  author = {Stegmann, Toon and Wiekmeijer, Anna-Sophia and Kwappenberg, Kitty and van Duikeren, Suzanne and Bhoelan, Farien and Bemelman, Denzel and Beenakker, Thomas J M and Krebber, Willem-Jan and Arens, Ramon and Melief, Cornelis J M},
  title = {Enhanced HPV16 E6/E7+ tumor eradication via induction of tumor-specific T cells by therapeutic vaccination with virosomes presenting synthetic long peptides},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2023},
  doi = {10.1007/s00262-023-03462-y}
}
Kostenlos starten →